Christopher Southan

Christopher Southan is currently a Fellow at multiple prestigious organizations, including the Royal Society of Biology and the Royal Society of Chemistry. Christopher also serves as an Adjunct Associate Professor at The University of New Mexico School of Medicine. With a background in biochemistry and virology, Christopher brings a wealth of experience to their work as a Data Science Competitive Intelligence Analyst at Medicines Discovery Catapult. Prior to their current roles, Christopher was the Owner and Principal Consultant at TW2Informatics and a Senior Cheminformatian at The IUPHAR/BPS Guide to PHARMACOLOGY. Christopher has also worked as a Contractor at AstraZeneca and held a Special Professor of Proteomics position at the University of Nottingham.